Follow us on:

Linkedin Facebook

ImmuPharma PLC London Investor Evening 26 February 2018

Immupharma plc
[shareaholic app="share_buttons" id_name="post_below_content"]

ImmuPharma PLC (LON:IMM), specialist drug discovery and development company, has today announced that Tim McCarthy, Chairman, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as agent in the recent £10 million fundraise by ImmuPharma.

 

The proceeds of the Placing allow the Company to make investment into potential indications emanating from the Company’s P140 platform, in addition to lupus. The Placing further strengthens the balance sheet and enhances ImmuPharma’s position in ongoing and future negotiations with potential partners for Lupuzor™.

The event will be held on Monday 26th February 2018 in London, EC2 and will commence at 6pm. Further details on the event will be provided upon registration. To Register your interest, please email [email protected] and [email protected] or call 0203 621 4120.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    immunodiagnostics

    ImmuPharma two specialist US healthcare investments of up to $6.30 million

    52 Grosvenor Garden, London SW1W 0AU

    ImmuPharma AGM Venue to be held at Grosvenor Garden

    Broker Ratings

    Market Risers: 3i Group plc, Hargreaves Lansdown, ImmuPharma, Marks and Spencer Group

    Peptides COVID

    ImmuPharma’s efforts in the fight against Covid-19 with Lupuzor™ and Ureka

    Broker Ratings

    Market Risers: Hargreaves Lansdown, ImmuPharma, ITV

    Broker Ratings

    Market Risers: ImmuPharma, International Consolidated Airlines Group, ITV, KEFI Minerals

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.